Physician profile
Alan Rudick
NPI 1508866971
$1,212.89
in general payments reported to CMS, 2019-2025
10 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $11.95 · 2022: $259 · 2023: $333 · 2024: $211 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $474 · Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $473.97 |
| Food and Beverage | $365.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $287.99 | 2024-2025 | |
| Inspire Medical Systems, INC. | $233.25 | 2023 | Inspire |
| Harmony Biosciences LLC | $185.98 | 2024-2025 | |
| Pulmonx Corporation | $134.09 | 2022 | |
| Penumbra, INC. | $125.00 | 2022 | |
| United Therapeutics Corporation | $100.00 | 2023 | |
| Mylan Specialty L.P. | $86.05 | 2019 | |
| Genzyme Corporation | $31.83 | 2024 | |
| Insmed, INC. | $16.75 | 2019 | |
| Glaxosmithkline, LLC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Rudick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.